SAN DIEGO, April 5, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (“Apricus Bio”) (Nasdaq:APRI) (http://www.apricusbio.com) announced today that Chairman, President and Chief Executive Officer, Dr. Bassam Damaj, was recently interviewed by WallStreetCorner.com, a New York-based financial publication. The interview is available at http://wallstreetcorner.com/daily.html.
